Business of the House

Nicholas Dakin Excerpts

Thursday 27th February 2014 Commons Chamber

[Mr Lansley]

I will, of course, talk to my hon. Friends at the Business, Innovation and Skills Department. However, I have to say to my hon. Friend that I do not think we are lecturing companies. We are being clear about what we regard as social responsibility, and that companies have a responsibility that extends not only to their shareholders and employees but to the wider society. All companies should recognise that. Where the Government have a substantial shareholding in a company, of course we should use that shareholding similarly—in a socially responsible way. We are aiming for, and have seen, a substantial reduction in bonuses in the banking sector, which I know is occurring in those companies in which the Government have a shareholding.

[Nic Dakin (Scunthorpe) (Lab)]

May we have a statement from the Health Secretary about the possibility of improving outcomes for pancreatic cancer patients through Abraxane?

[Mr Lansley]

I will ask my right hon. Friend the Health Secretary whether there is any opportunity to update the House. A diagnosis of pancreatic cancer continues to be very serious. The hon. Gentleman knows that survival rates for pancreatic cancer are very low in comparison with those for many other cancers, on which we have made considerable progress. In the Cancer Research UK laboratories in my constituency, I have seen the work being done on potential routes to the diagnosis and treatment of pancreatic cancer, but it is early days and I fear that the number of projects with good lines of inquiry are still few.